Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse
- PMID: 25757463
- DOI: 10.1042/CS20140444
Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse
Abstract
Myocardial ischaemia-reperfusion (MIR) triggers a sterile inflammatory response important for myocardial healing, but which may also contribute to adverse ventricular remodelling. Such inflammation is initiated by molecular danger signals released by damaged myocardium, which induce innate immune responses by activating toll-like receptors (TLRs). Detrimental roles have been recently reported for TLR2, TLR3 and TLR4. The role of other TLRs is unknown. We therefore evaluated the role of TLR5, expressed at high level in the heart, in the development of myocardial damage and inflammation acutely triggered by MIR. TLR5(-/-) and wild-type (WT) mice were exposed to MIR (30 min ischaemia, 2 h reperfusion). We measured infarct size, markers of cardiac oxidative stress, myocardial phosphorylation state of mitogen-activated protein (MAP) kinases and AKT, expression levels of chemokines and cytokines in the heart and plasma, as well as cardiac function by echography and conductance volumetry. TLR5-deficient mice had normal cardiac morphology and function under physiological conditions. After MIR, the absence of TLR5 promoted an increase in infarct size and myocardial oxidative stress. Lack of TLR5 fostered p38 phosphorylation, reduced AKT phosphorylation and markedly increased the expression of inflammatory cytokines, whereas it precipitated acute LV (left ventricle) dysfunction. Therefore, contrary to the detrimental roles of TLR2, TLR3 and TLR4 in the infarcted heart, TLR5 is important to limit myocardial damage, inflammation and functional compromise after MIR.
Similar articles
-
Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.Cardiovasc Res. 2019 Oct 1;115(12):1791-1803. doi: 10.1093/cvr/cvz057. Cardiovasc Res. 2019. PMID: 30830156
-
Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.Circ Res. 2020 Sep 25;127(8):953-973. doi: 10.1161/CIRCRESAHA.119.315807. Epub 2020 Jun 30. Circ Res. 2020. PMID: 32600176
-
C/EBP homologous protein deficiency attenuates myocardial reperfusion injury by inhibiting myocardial apoptosis and inflammation.Arterioscler Thromb Vasc Biol. 2011 May;31(5):1124-32. doi: 10.1161/ATVBAHA.111.224519. Epub 2011 Feb 17. Arterioscler Thromb Vasc Biol. 2011. PMID: 21330607
-
The innate immune response in reperfused myocardium.Cardiovasc Res. 2012 May 1;94(2):276-83. doi: 10.1093/cvr/cvs018. Epub 2012 Jan 20. Cardiovasc Res. 2012. PMID: 22266751 Review.
-
The Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium.Cardiovasc Drugs Ther. 2020 Feb;34(1):123-131. doi: 10.1007/s10557-020-06946-6. Cardiovasc Drugs Ther. 2020. PMID: 32062794 Free PMC article. Review.
Cited by
-
Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice.Theranostics. 2020 Sep 2;10(24):11013-11025. doi: 10.7150/thno.47516. eCollection 2020. Theranostics. 2020. PMID: 33042267 Free PMC article.
-
Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection.Cardiol Res Pract. 2019 May 28;2019:6935147. doi: 10.1155/2019/6935147. eCollection 2019. Cardiol Res Pract. 2019. PMID: 31275641 Free PMC article. Review.
-
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.Circ Res. 2016 Jun 24;119(1):91-112. doi: 10.1161/CIRCRESAHA.116.303577. Circ Res. 2016. PMID: 27340270 Free PMC article. Review.
-
Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness.Sci Rep. 2017 Feb 16;7:42688. doi: 10.1038/srep42688. Sci Rep. 2017. PMID: 28202909 Free PMC article.
-
Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success.Front Immunol. 2020 Dec 8;11:599511. doi: 10.3389/fimmu.2020.599511. eCollection 2020. Front Immunol. 2020. PMID: 33363540 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
